Head Benefit Risk and Pharmacoepidemiology

Location: Gentilly, France; up to 25% travel may be required.

Salary: €180,000–€240,000 per year.

Company

hirify.global is a biopharmaceutical company developing medicines through patient-focused research, AI, data, and digital platforms.

What you will do

• Define epidemiology and benefit-risk strategies for products across discovery, development, and post-marketing.
• Oversee epidemiology safety studies, including PASS, to meet regulatory requirements.
• Lead risk assessments and structured benefit-risk evaluations for senior safety governance bodies.
• Manage and develop a multidisciplinary Epi & BR team, including capability building, career development, and budget management.
• Develop rapid-access and analysis processes for real-world data used in safety evaluation.
• Lead external collaborations, scientific partnerships, publications, presentations, and interactions with regulators and academia.

Requirements

• Doctoral degree in biomedical sciences or public health, or an M.D. with an advanced degree in a related field.
• At least 15 years of relevant professional experience with a Ph.D., or 12 years with an M.D.; at least 8 years in the pharmaceutical industry is preferred.
• Experience in epidemiology, benefit-risk evaluation, risk management, signal detection and management, and patient safety sciences.
• Leadership experience with large, diverse teams and external industry or public-private partnerships.
• Strong statistics, biostatistics, quantitative analysis, real-world data, and regulatory guideline knowledge.
• Scientific publication track record and experience across post-marketing and clinical development activities.

Culture & Benefits

• Supportive, future-focused environment with international career development opportunities.
• Health, wellbeing, prevention, and wellness benefits.
• At least 14 weeks of gender-neutral parental leave.
• Employee rewards and benefits programs.
• Opportunity to work with AI, data, and digital platforms in drug discovery and development.